Toxicidad dermatológica en pacientes bajo tratamiento radioquimioterapéutico del hospital “Teodoro Maldonado Carbo”, Guayaquil
Contenido principal del artículo
Resumen
Detalles del artículo

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Citas
Abril G. Cuidados de la Piel en el paciente Oncológico. Boletín oncológico. 2008 Feb [ cited 2008 Feb 28 ]; [ 1 p]. Available from: http://www.boloncol.com/boletin-24/cuidados-de-la-piel-enel-paciente-oncologico.html.
Chemotherapy Source Book, the, 4th Edition. Perry, Michael C., editores. Dermatologic Toxicity. Missouri: Lippincott Williams & Wilkins; 2008. Chapter 15.
American academy of dermatology. Cutaneous Side Effects Common with Erlotinib, Cetuximab. Medscape. 2008 [cited 2008]; [About 1 p ]. Available from http://www.medscape.com/viewarticle/544376.
Peterson DE, Bensadoun RJ, Roila F. Management of oral and gastrointestinal mucositis: ESMO clinical practice guidelines. Ann Oncol. 208; 21(suppl 5):v261–5.
START Trialists’ Group, Bentzen SM, Agrawal RK, et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008;9:331-341.
Harris DJ, Eilers J, Harriman A et al. Putting evidence into practice: evidencebased interventions for the management of oral mucositis. Clin J Oncol Nurs. 2008; 12:141–52.
Haddad RI, Shin DM. Recent advances in head and neck cancer. N Engl J Med. 2008; 359:1143–54.
Roach M, Bae K, Speight J, et al. Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610. J Clin Oncol 2008;26:585-591.